Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Shengtao Ye"'
Autor:
Ying Zheng, Shengtao Ye, Shiyu Huang, Yang Cheng, Yanqiu Zhang, Yingrong Leng, Mengmeng He, Enyi Wu, Junxin Chen, Lingyi Kong, Hao Zhang
Publikováno v:
Advanced Science, Vol 11, Iss 30, Pp n/a-n/a (2024)
Abstract Acquired resistance represents a critical clinical challenge to molecular targeted therapies such as tyrosine kinase inhibitors (TKIs) treatment in hepatocellular carcinoma (HCC). Therefore, it is urgent to explore new mechanisms and therape
Externí odkaz:
https://doaj.org/article/4ce8fd035ee042efb8d39661d9516f77
Autor:
Yanqiu Zhang, Ruirui Dong, Huiling Zhou, Jingyi Wang, Jianfei Shi, Shengtao Ye, Yang Cheng, Yingrong Leng, Wenjun Xu, Lingyi Kong, Hao Zhang
Publikováno v:
Journal of Agricultural & Food Chemistry; 7/24/2027, Vol. 72 Issue 29, p16323-16333, 11p
Autor:
Yanqiu, Zhang, Shengtao, Ye, Weijia, Lu, Jiawen, Zhong, Yingrong, Leng, Ting, Yang, Jun, Luo, Wenjun, Xu, Hao, Zhang, Lingyi, Kong
Publikováno v:
Hepatology. 77:1670-1687
Nonalcoholic fatty liver disease and its progressive form, nonalcoholic steatohepatitis (NASH), are rapidly becoming the top causes of hepatocellular carcinoma (HCC). Currently, there are no approved therapies for the treatment of NASH. DEAD-box prot
Publikováno v:
Chinese Chemical Letters. 33:4121-4125
Two novel seco-polycyclic polyprenylated acylphloroglucinols (PPAPs), hyperbenzones A (1) and B (2), were isolated from the roots of Hypericum beanii, together with one known biosynthetic congener 3. Compound 1 incorporates a 6/5/5 ring system with a
Autor:
Ting Yang, Enyi Wu, Xiaoyun Zhu, Yingrong Leng, Shengtao Ye, Ruirui Dong, Jiaman Liu, Jiawen Zhong, Ying Zheng, Wenjun Xu, Jun Luo, Lingyi Kong, Hao Zhang
Publikováno v:
Phytomedicine : international journal of phytotherapy and phytopharmacology. 107
Liver fibrosis is a common scarring response and may ultimately lead to liver cancer, unfortunately, there is currently no effective antifibrotic drug approved for human use. Limonoids exhibit a broad spectrum of biological activities; however, the p
Autor:
Shengtao Ye, Xiaoyun Zhu, Meihui Zhang, Ting Yang, Ling-Yi Kong, Xin-lin Chen, Yingrong Leng, Dong‐ke Yu, Hao Zhang, Jian-Guang Luo, Jie Li, Yanqiu Zhang
Publikováno v:
British journal of pharmacologyREFERENCES. 178(17)
Background and purpose Liver fibrosis is one of the leading causes of morbidity and mortality worldwide but lacks any acceptable therapy. The transcription factor glioma-associated oncogene homologue 1 (GLI1) is a potentially important therapeutic ta
Autor:
Ting Yang, Jie Li, Xin-lin Chen, Zhang Hao, Yanqiu Zhang, Yingrong Leng, Shengtao Ye, LY Kong, Zhang Meihui, Xiaoyun Zhu, Luo Jianguang
Background and Purpose: Liver fibrosis is one of the leading causes of morbidity and mortality worldwide of which no acceptable therapy exists. Accumulating evidence supports that glioma-associated oncogene homologue 1(GLI1) is a potentially importan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de92ae0f675c9eabc8596b4fe2012c2e
https://doi.org/10.22541/au.160688352.26104394/v1
https://doi.org/10.22541/au.160688352.26104394/v1
Autor:
Yanqiu Zhang, Yingrong Leng, Xiaoyun Zhu, Ling-Yi Kong, Jie Li, Hao Zhang, Shengtao Ye, Meihui Zhang, Ting Yang
Publikováno v:
Free radical biologymedicine. 164
Non-alcoholic steatohepatitis (NASH) is the progressive stage of non-alcoholic fatty liver disease that may ultimately lead to cirrhosis and liver cancer, and there are few therapeutic options for its treatment. Physalin B (PB), a withanolide isolate
Autor:
Jie Li, Ting Yang, Meihui Zhang, Xiaoyun Zhu, Shengtao Ye, Yingrong Leng, Hao Zhang, Yanqiu Zhang, Ling-Yi Kong
Publikováno v:
Journal of hepatology. 75(2)
Background & Aims Cholestatic liver diseases comprise a variety of disorders of bile formation and/or flow which generally result in progressive hepatobiliary injury. Regulation of bile acid (BA) synthesis and homeostasis is a promising strategy for